Research Technologies

research-technologies-740

Roche is at the forefront when it comes to collaboration with biotechs at all development stages to drive the application of technology and modality platforms that have the potential to transform discovery as well as generate innovative medicines beyond the standard of care.



 

Partnering opportunities we are looking for:

  • Novel modalities and enabling technologies to expand the druggable target space
  • Targeted or intracellular delivery
  • Artificial intelligence for drug discovery
  • Genomic Medicine platforms

Example partnerships

Skyhawk – research collaboration to discover and develop small molecule RNA splicing modifiers for oncology and neurodegenerative diseases

Heptares – research collaboration to discover and develop novel medicines that modulate G-protein-coupled receptor targets across a range of diseases

Arrakis Therapeutics - research collaboration to discover and develop RNA-targeted small molecules against a broad set of targets across Roche's R&D areas

Vividion Therapeutics - research collaboration to discover and develop compounds targeting novel E3 ligases and a range of oncology and immunology therapeutic targets based on Vividion's covalent chemistry

Bicycle Therapeutics - research collaboration to discover and develop immunomodulatory bicyclic peptides for the treatment of cancer
 

Your dedicated partnering leads in Research Technologies

Barbara Lueckel

Barbara Lueckel Head of Research Technologies, Pharma Partnering

Tapan Maniar

Mark Schiebler Search & Evaluation Lead Research Technologies, Pharma Partnering

roche.com partnering

If you have an opportunity, we would like to hear from you.

Contact us

Case study

Perspectives

Related links